Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day
April 1999
DuPont is now marketing Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day.
Sustiva is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...in the same class as Rescriptor and Viramune.
It seems to be as potent as a protease inhibitor...when added to nucleoside inhibitors such as Retrovir and 3TC.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive